Related Experiment Videos
RNA mimetics: oligoribonucleotide N3'-->P5' phosphoramidates
1Lynx Therapeutics Inc., 3832 Bay Center Place, Hayward, CA 94545, USA. sgryaznov@geron.com
Nucleic Acids Research
|September 2, 1998
Summary
Novel RNA mimetics, oligoribonucleotide N3'-->P5' phosphoramidates, exhibit high resistance to enzymatic hydrolysis. These stable compounds form robust duplexes and triplexes, showcasing their potential as hydrolytically stable RNA mimics.
Area of Science:
- Medicinal Chemistry
- Organic Chemistry
- Molecular Biology
Background:
- Native RNA is susceptible to enzymatic degradation, limiting its therapeutic applications.
- Developing stable RNA mimics is crucial for advancing nucleic acid-based therapeutics and diagnostics.
Purpose of the Study:
- To synthesize and characterize novel oligoribonucleotide N3'-->P5' phosphoramidates as RNA mimetics.
- To evaluate the hydrolytic stability and duplex/triplex formation properties of these novel phosphoramidates.
Main Methods:
- Synthesis of key phosphoramidite monomers.
- Solid-phase synthesis of oligoribonucleotide N3'-->P5' phosphoramidates.
- Enzymatic hydrolysis assays using snake venom phosphodiesterase.
- Thermal denaturation studies (Tm) to assess duplex and triplex stability.
Main Results:
- Oligoribophosphoramidates demonstrated high resistance to enzymatic hydrolysis.
- Stable duplexes were formed with complementary DNA and RNA strands, showing increased melting temperatures (Tm) of 5-14°C.
- Enhanced thermal stability was observed in ribophosphoramidate homoduplexes (ΔTm +9.5°C) and DNA triplexes (ΔTm +14.3°C).
Conclusions:
- Oligoribonucleotide N3'-->P5' phosphoramidates are hydrolytically stable and form stable nucleic acid complexes.
- These properties make them promising candidates for structural and functional RNA mimetics in various applications.